🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › California › Baldwin Park

Qorannoo klinikaalii Myelodysplastic Syndromes Baldwin Park, CA keessatti

Qorannoo 26 Myelodysplastic Syndromes f Baldwin Park fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope, Duarte · Miili 4 fagaatti
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • City of Hope - Duarte, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • City of Hope - Comprehensive Cancer Center (CCC), Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope National Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06846606

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • City of Hope, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Namoota walitti qabaa jiraSadarkaa 2
  • City of Hope National Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04419649

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT06498973

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06996119

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Namoota walitti qabaa jiraSadarkaa 2
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06815003

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT03113643

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT06847867

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Namoota walitti qabaa jira
  • Beckman Research Institute of City of Hope, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT05297734

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT06195891

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06146257

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06059391

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT06543381

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Namoota walitti qabaa jiraSadarkaa 2
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 10 hanga 30 · Saalaa hunda · Haaromfame 04-Mud-2025 · NCT05194397

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Duarte · Miili 4 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Elb-2025 · NCT06297941

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • City of Hope National Medical Center, Duarte · Miili 4 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2024 · NCT04243785

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Baldwin Park keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.